Interview with Dr Jim Thomas and Karen Lackey
What role do Biologics play in the context of novel therapeutics? Jim: Biologics are a significant and growing portion of the arsenal of therapeutics used…
Learn more
Interview with Barbara Bachler-Konetzki about Evotec’s integrated antibody discovery capabilities
What were the limitations of previous hybridoma-based approaches? Although the development of the hybridoma technology was a landmark event, the methodology still faced the limitation…
Interview with RANDAL R. KETCHEM about the optimization of antibodies
How does optimization of antibodies improve development? Just – Evotec Biologics has developed a molecular optimisation platform for monoclonal antibodies to increase productivity, eliminate potential…
Biologics manufacturing without the big bioreactors
Producing therapeutic antibodies is expensive and difficult, but drug-makers have unprecedented flexibility in plant design through a new modular biologics manufacturing platform that streamlines the…
Designing Feature-Controlled Humanoid Antibody Discovery Libraries Using Generative Adversarial Networks
Just – Evotec Biologics has compiled a library of a new class of humanoid antibodies using a novel, AI-derived approach. Antibodies are proteins produced and…
Shocking Data on Parcel Shipments of Protein Solutions
Journal of Pharmaceutical Sciences
Evaluation of Crystal Zenith Microtiter Plates for High-Throughput Formulation Screening
Journal of Pharmaceutical Sciences
Adapting the chemical unfolding assay for high-throughput protein screening using experimental and spectroscopic corrections
Journal of Pharmaceutical Sciences